Meropenem for injection 1.0g&0.5g/vial

Products

Information

Meropenem for injection 1.0g&0.5g/vial
Distribution Areas
North America (USA, Canada)Europe - EU countriesSouth America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
China
All categories
AntibioticsAPIs (Active Pharmaceutical Ingredients)Innovative APIsProducts
Main Categories
APIs (Active Pharmaceutical Ingredients)
MPLA (Monophosphoryl Lipid A)MPLA (Monophosphoryl Lipid A) refers to monophosphoryl lipid A, an effective, safe and non-toxic vaccine adjuvant. It is a highly specific TLR4 agonist that can activate the natural immune response, induce the production of cytokines, and increase the antigen uptake, antigen presentation and activation of specific T cells by antigen-presenting cells such as dendritic cells and monocytes. However, as a bacterial derivative, natural MPLA has many risks such as microbial contamination, unstable quality and sustainable supply. Therefore, our company has developed a fully synthetic monoph...

Log in

See all the content and easy-to-use features by logging in or registering!